Percutaneous microwave ablation of pulmonary nodules under CT guidance: study progress of safety, effectiveness and complication

doi:10.19983/j.issn.2096-8493.20250147

Abstract

Abstract:

With the popularization of computed tomography (CT) screening, the detection rate of pulmonary nodules has significantly increased. At present, treatment for pulmonary nodules mainly relies on traditional surgical operation, for which although its effectiveness is definite, it goes with large trauma and slow recovery, thus some patients cannot tolerate it due to poor heart and lung functions. In recent years, CT-guided percutaneous microwave ablation (PMWA), as a minimally invasive treatment technique, has shown promising application prospects in the local treatment of pulmonary nodules. The authors aim to explore the technical principles, safety features, clinical effectiveness and complication management strategies of PMWA, and to present the challenges and future development directions faced by this technology, providing more comprehensive theoretical basis and practical guidance for clinical medical staff to provide comprehensive treatment of pulmonary nodules.

Key words: Microwave ablation, Sarcoidosis, pulmonary, Safety, Efficacy, Postoperative complications, Tomography scanner, X-ray computer

CLC Number:

R734.2

Gao Qian, Lu Nihong, Yang Yan. Percutaneous microwave ablation of pulmonary nodules under CT guidance: study progress of safety, effectiveness and complication[J]. Journal of Tuberculosis and Lung Disease , 2026, 7(2): 262-267. doi: 10.19983/j.issn.2096-8493.20250147

Figures/Tables 3

References 42

[1]	中华医学会呼吸病学分会, 中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2024年版). 中华结核和呼吸杂志, 2024, 47(8):716-729. doi:10.3760/cma.j.cn112147-20231109-00300.
[2]	张洁, 李杰, 刘澄英. 良、恶性肺结节临床特征及影响因素分析. 江苏医药, 2024, 50(12): 1242-1245. doi:10.19460/j.cnki.0253-3685.2024.12.012.
[3]	Zhang Q, Wu X, Yang H, et al. Advances in the Treatment of Pulmonary Nodules. Respiration, 2024, 103(3):134-145. doi:10.1159/000535824.
[4]	Izzo F, Granata V, Grassi R, et al. Radiofrequency Ablation and Microwave Ablation in Liver Tumors:An Update. Oncologist, 2019, 24(10):e990-e1005. doi:10.1634/theoncologist.2018-0337.
[5]	Lubner MG, Brace CL, Hinshaw JL, et al. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol, 2010, 21(8): S192-S203. doi:10.1016/j.jvir.2010.04.007.
[6]	Iezzi R, Cioni R, Basile D, et al. Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study). Eur Radiol, 2021, 31(4): 2173-2182. doi:10.1007/s00330-020-07299-2.
[7]	Yu J, Cheng ZG, Han ZY, et al. Period-Dependent Survival Benefit of Percutaneous Microwave Ablation for Hepatocellular Carcinoma: A 12-Year Real-World, Multicentric Experience. Liver Cancer, 2022, 11(4): 341-353. doi:10.1159/000522134. pmid: 35978603
[8]	Aarts BM, Gomez FM, Lopez-yurda M, et al. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis. Eur Radiol, 2023, 33(2): 1040-1049. doi:10.1007/s00330-022-09110-w.
[9]	Dong F, Wu Y, Li W, et al. Advancements in microwave ablation for tumor treatment and future directions. iScience. 2025, 28(4):112175. doi:10.1016/j.isci.2025.112175.
[10]	赵玉彪, 张洪杰, 张覃, 等. CT引导下微波消融肺结节联合术中穿刺活检的临床应用及预防出血措施分析. 影像研究与医学应用, 2024, 8(7): 177-179. doi:10.3969/j.issn.2096-3807.2024.07.058.
[11]	Ward RC, Healey TT, Dupuy DE. Microwave ablation devices for interventional oncology. Expert Rev Med Devices. 2013, 10(2):225-238. doi:10.1586/erd.12.77. pmid: 23480091
[12]	Ye X, Fan W, Wang H, et al. Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition). J Cancer Res Ther, 2018, 14(4): 730-744. doi:10.4103/jcrt.JCRT_221_18. pmid: 29970646
[13]	中国临床肿瘤学会(CSCO)肿瘤消融治疗专家委员会, 中国医师协会肿瘤消融治疗技术专家组, 中国抗癌协会肿瘤消融治疗专业委员会, 等. 影像引导下热消融治疗原发性和转移性肺部肿瘤临床实践指南(2021年版). 中华内科杂志, 2021, 60(12):1088-1105. doi:10.3760/cma.j.cn112138-20210814-00554.
[14]	叶欣, 王俊, 危志刚, 等. 热消融治疗肺部亚实性结节专家共识(2021年版). 中国肺癌杂志, 2021, 24(5): 305-322. doi:10.3779/j.issn.1009-3419.2021.101.14.
[15]	辛少伟, 杨阳, 高峰, 等. 38例肺癌的CT引导下微波消融安全性及初步疗效临床总结. 现代生物医学进展, 2024, 24(23): 4444-4448. doi:10.13241/j.cnki.pmb.2024.23.009.
[16]	刘豪, 杨云龙. CT引导经皮微波消融治疗肺结节的安全性及短期疗效评价. 中国临床研究, 2022, 35(7): 982-985. doi:10.13429/j.cnki.cjcr.2022.07.019.
[17]	Yang X, Jin Y, Lin Z, et al. Microwave ablation for the treatment of peripheral ground-glass nodule-like lung cancer: Long-term results from a multi-center study. J Cancer Res Ther, 2023, 19(4): 1001-1010. doi:10.4103/jcrt.jcrt_1436_23. pmid: 37675729
[18]	Reisenauer JS, Eiken PW, Callstrom MR, et al. A prospective trial of CT-guided percutaneous microwave ablation for lung tumors. J Thorac Dis, 2022, 14(4):939-951. doi:10.21037/jtd-21-1636. pmid: 35572874
[19]	Li B, Gao S, Mao J, et al. A retrospective study of microwave ablation and thoracoscopic surgery for multiple primary lung cancer: a propensity score matching analysis. Front Surg, 2025, 12: 1547048. doi:10.3389/fsurg.2025.1547048.
[20]	荣振华, 焦言, 纪永琪, 等. 肺癌合并重度慢性阻塞性肺疾病的微波消融治疗临床分析. 影像研究与医学应用, 2020, 4(24): 21-22. doi:10.3969/j.issn.2096-3807.2020.24.011.
[21]	Cui SP, Zhao Q, Wang J, et al. Exploring the impact of variable power outputs on the efficacy and safety during microwave ablation for lung carcinoma: a real-world study. J Thorac Dis, 2024, 16(8): 5031-5041. doi:10.21037/jtd-24-557.
[22]	张树亮, 张孝勇, 林玮, 等. 基于胸外科临床实践的穿刺导航机器人辅助肺结节消融技术进展. 机器人外科学杂志(中英文), 2025, 6(7): 1080-1089. doi:10.12180/j.issn.2096-7721.2025.07.002.
[23]	Zhang L, Zhang M, Wang J, et al. Immunogenic change after percutaneous microwave ablation in pulmonary malignancies: Variation in immune cell subsets and cytokines in peripheral blood. Front Immunol, 2022, 13: 1069192. doi:10.3389/fimmu.2022.1069192.
[24]	Cao B, Liu M, Wang L, et al. Remodelling of tumour microen-vironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer. Nat Commun, 2022, 13(1):6203. doi:10.1038/s41467-022-33968-5.
[25]	刘宝东, 支修益. 影像引导下热消融治疗肺部肿瘤的局部疗效评价. 中国医学前沿杂志(电子版), 2015, (2):11-14. doi:10.3969/j.issn.1674-7372.2015.02.004.
[26]	Palussière J, Marcet B, Descat E, et al. Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up. Cardiovasc Intervent Radiol, 2011, 34(5): 989-997. doi:10.1007/s00270-010-0048-z. pmid: 21127867
[27]	Abtin F, De Baere T, Dupuy DE, et al. Updates on Current Role and Practice of Lung Ablation. J Thorac Imaging, 2019, 34(4): 266-277. doi:10.1097/RTI.0000000000000417.
[28]	Geevarghese R, Alexander ES, Elsakkaa A, et al. Outcomes following microwave ablation of 669 primary and metastatic lung malignancies. Eur Radiol, 2026, 36(3):2295-2304. doi:10.1007/s00330-025-11973-8.
[29]	李惠, 叶欣. 肺癌微波消融治疗研究十年现状. 实用肿瘤杂志, 2024, 39(4):291-298. doi:10.13267/j.cnki.syzlzz.2024.045.
[30]	Chan MV, Huo YR, Cao C, et al. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis. Eur Radiol, 2021, 31(7): 5421-5433. doi:10.1007/s00330-020-07634-7. pmid: 33449192
[31]	Wei Z, Zhang K, Ye X, et al. Computed tomography-guided percutaneous microwave ablation combined with osteoplasty for palliative treatment of painful extraspinal bone metastases from lung cancer. Skeletal Radiol, 2015, 44(10): 1485-1490. doi:10.1007/s00256-015-2195-4. pmid: 26112311
[32]	Yang X, Ye X, Zheng A, et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol, 2014, 110(6): 758-763. doi:10.1002/jso.23701. pmid: 24965604
[33]	张达毅, 蔡跃东, 王晓聪. 肺结节患者微波消融术治疗效果的影响因素分析. 福建医药杂志, 2025, 47(1): 43-46. doi:10.20148/j.fmj.2025.01.013.
[34]	沈旭, 沈诚, 肖丛佳, 等. 多发肺结节消融治疗的研究进展. 中国胸心血管外科临床杂志, 2025, 32(3): 401-405. doi:10.7507/1007-4848.202306025.
[35]	Zhang HF, Liao MY, Zhu DY, et al. Lung radiodensity along the needle passage is a quantitative predictor of pneumothorax after CT-guided percutaneous core needle biopsy. Clin Radiol, 2018, 73(3):319.e1-e319.e7. doi:10.1016/j.crad.2017.10.010.
[36]	王丽娜, 刘建, 史宏璐, 等. CT引导下经皮肺微波消融术中疼痛的风险评估. 医学影像学杂志, 2025, 35(2): 55-59. doi:10.20258/j.cnki.1006-9011.2025.02.013.
[37]	张亚楠, 吴献华, 仲楼, 等. CT引导下肺癌微波消融后空洞形成的相关研究. 实用放射学杂志, 2019, 35(1): 106-109. doi:10.3969/j.issn.1002-1671.2019.01.027.
[38]	Xu C, Wang Y, Li Y, et al. A major complication of microwave ablation in a patient with surgically treated ground-glass opacity. J Cancer Res Ther, 2025, 21(2): 518-521. doi:10.4103/jcrt.jcrt_2479_24. pmid: 40317160
[39]	Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol, 2008, 15(6): 1765-1774. doi:10.1245/s10434-008-9848-7. pmid: 18368456
[40]	刘强. 经皮CT引导下肺结节微波消融术后并发症及其危险因素的研究. 南宁:广西医科大学, 2022. doi:10.27038/d.cnki.ggxyu.2022.000077.
[41]	Wu CC, Maher MM, Shepard JA. Complications of CT-guided percutaneous needle biopsy of the chest: prevention and management. AJR Am J Roentgenol, 2011, 196(6): W678-W682. doi:10.2214/AJR.10.4659.
[42]	中国抗癌协会肿瘤介入学专业委员会, 中国抗癌协会肿瘤介入学专业委员会胸部肿瘤诊疗专家委员会. 胸部肿瘤经皮穿刺活检中国专家共识(2020版). 中华医学杂志, 2021, 101(3):185-198. doi:10.3760/cma.j.cn112137-20200907-02576.

效果	CT (肿瘤大小)	CT (肿瘤密度)	PET或 PET-CT
完全消融	缩小或不变	无强化区	无代谢区
不完全消融	不变或增大	强化区无变化	高代谢区无变化
局部进展	增大10mm	新出现或强化区增大	新出现或高代谢区增大